Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis

Satoshi Kawatsu; Shingo Takahara; Kou Sakatsume; Keisuke Kanda; Tomoyuki Suzuki; Shintaro Katahira; Hidenori Fujiwara; Osamu Adachi; Masatoshi Akiyama; Kiichiro Kumagai; Shunsuke Kawamoto; Yoshikatsu Saiki

Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis

Satoshi Kawatsu, Shingo Takahara, Kou Sakatsume, Keisuke Kanda, Tomoyuki Suzuki, Shintaro Katahira, Hidenori Fujiwara, Osamu Adachi, Masatoshi Akiyama, Kiichiro Kumagai, Shunsuke Kawamoto, Yoshikatsu Saiki

Tohoku University

Research output: Contribution to journal › Article › peer-review

Abstract

Tolvaptan is a new selective vasopression V2-receptor antagonist. We report our experience with a use of tolvaptan for preoperative fluid management in a patient with severe constrictive pericarditis. A 66-year-old man presented with heart failure symptoms derived from constrictive pericarditis. Chest X-ray showed right pleural effusion and chest computed tomography demonstrated severe pericardial calcification. Despite that he received optimal conventional medical treatments, his hemodynamic condition further exacerbated during hospitalization. We administered tolvaptan in an attempt to optimize preoperative fluid management. Tolvaptan was found to be remarkably effective in that regard. The body weight decreased and the heart failure symptoms improved. Pericardiectomy was performed successfully, and he recovered uneventfully.

Original language	English
Pages (from-to)	121-125
Number of pages	5
Journal	Kyobu geka. The Japanese journal of thoracic surgery
Volume	69
Issue number	2
Publication status	Published - 2016 Feb 1

Cite this

@article{f691144a9f254945a1d74743fd846680,

title = "Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis",

abstract = "Tolvaptan is a new selective vasopression V2-receptor antagonist. We report our experience with a use of tolvaptan for preoperative fluid management in a patient with severe constrictive pericarditis. A 66-year-old man presented with heart failure symptoms derived from constrictive pericarditis. Chest X-ray showed right pleural effusion and chest computed tomography demonstrated severe pericardial calcification. Despite that he received optimal conventional medical treatments, his hemodynamic condition further exacerbated during hospitalization. We administered tolvaptan in an attempt to optimize preoperative fluid management. Tolvaptan was found to be remarkably effective in that regard. The body weight decreased and the heart failure symptoms improved. Pericardiectomy was performed successfully, and he recovered uneventfully. ",

author = "Satoshi Kawatsu and Shingo Takahara and Kou Sakatsume and Keisuke Kanda and Tomoyuki Suzuki and Shintaro Katahira and Hidenori Fujiwara and Osamu Adachi and Masatoshi Akiyama and Kiichiro Kumagai and Shunsuke Kawamoto and Yoshikatsu Saiki",

year = "2016",

month = feb,

day = "1",

language = "English",

volume = "69",

pages = "121--125",

journal = "Kyobu geka. The Japanese journal of thoracic surgery",

issn = "0021-5252",

publisher = "Nankodo Co., Ltd.",

number = "2",

}

TY - JOUR

T1 - Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis

AU - Kawatsu, Satoshi

AU - Takahara, Shingo

AU - Sakatsume, Kou

AU - Kanda, Keisuke

AU - Suzuki, Tomoyuki

AU - Katahira, Shintaro

AU - Fujiwara, Hidenori

AU - Adachi, Osamu

AU - Akiyama, Masatoshi

AU - Kumagai, Kiichiro

AU - Kawamoto, Shunsuke

AU - Saiki, Yoshikatsu

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Tolvaptan is a new selective vasopression V2-receptor antagonist. We report our experience with a use of tolvaptan for preoperative fluid management in a patient with severe constrictive pericarditis. A 66-year-old man presented with heart failure symptoms derived from constrictive pericarditis. Chest X-ray showed right pleural effusion and chest computed tomography demonstrated severe pericardial calcification. Despite that he received optimal conventional medical treatments, his hemodynamic condition further exacerbated during hospitalization. We administered tolvaptan in an attempt to optimize preoperative fluid management. Tolvaptan was found to be remarkably effective in that regard. The body weight decreased and the heart failure symptoms improved. Pericardiectomy was performed successfully, and he recovered uneventfully.

AB - Tolvaptan is a new selective vasopression V2-receptor antagonist. We report our experience with a use of tolvaptan for preoperative fluid management in a patient with severe constrictive pericarditis. A 66-year-old man presented with heart failure symptoms derived from constrictive pericarditis. Chest X-ray showed right pleural effusion and chest computed tomography demonstrated severe pericardial calcification. Despite that he received optimal conventional medical treatments, his hemodynamic condition further exacerbated during hospitalization. We administered tolvaptan in an attempt to optimize preoperative fluid management. Tolvaptan was found to be remarkably effective in that regard. The body weight decreased and the heart failure symptoms improved. Pericardiectomy was performed successfully, and he recovered uneventfully.

UR - http://www.scopus.com/inward/record.url?scp=84981485563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84981485563&partnerID=8YFLogxK

M3 - Article

C2 - 27075153

AN - SCOPUS:84981485563

SN - 0021-5252

VL - 69

SP - 121

EP - 125

JO - Kyobu geka. The Japanese journal of thoracic surgery

JF - Kyobu geka. The Japanese journal of thoracic surgery

IS - 2

ER -

Preoperative Use of Tolvaptan in a Patient with Constrictive Pericarditis

Abstract

Other files and links

Fingerprint

Cite this